04272018Headline:

Southeast Pennsylvania, Pennsylvania

HomePennsylvaniaSoutheast Pennsylvania

Derek T. Braslow

Plaintiffs Seek MDL for PPI Lawsuits

On October 17th, Plaintiff’s filed a motion for transfer with the U.S. Judicial Panel for Multidistrict Litigation (JPML) in an attempt to consolidate numerous lawsuits regarding kidney damage from the use of proton pump inhibitors (PPIs). PPIs include popular prescription […]

Derek T. Braslow

Several Studies Focus on Risks of Fluoroquinolones

A recent study by the Journal of the American Medical Association (JAMA) concluded that one out of three people with a sinus infection, sore throat or earache is prescribed the wrong antibiotic. Most people probably prefer better odds. Perhaps even […]

Derek T. Braslow

Do PDE5 Inhibitors Cause Skin Cancer?

According to recent lawsuits, many believe the answer is yes. More commonly known as erectile dysfunction drugs, PDE5 inhibitors—so named because they block a specific enzyme that can cause restricted blood flow in certain muscle tissue—have been associated with an […]

Derek T. Braslow

OxyContin: The List of Lawsuits Gets Longer

In a recent post, I considered the history of the prescription drug OxyContin that, in the minds of many, has singularly opened a Pandora’s Box of widespread addiction and abuse—affecting an ever growing number of individuals and even entire communities […]

Derek T. Braslow

The OxyContin Epidemic: Was it Orchestrated?

While it’s hard to believe that anyone would have purposely brought about the rampant opioid abuse currently engulfing our nation, it’s obvious to many, judging by the long string of lawsuits that have paraded through our courts for the past […]

Derek T. Braslow

Health concerns over talc continue as U.S. courts sift through evidence

In the latest news concerning the link between ovarian cancer and Johnson & Johnson’s talcum powder, a New Jersey judge has made a ruling that could influence the outcome of over 200 pending talc lawsuits against Johnson & Johnson in […]

Derek T. Braslow

Clinical Trials Come Into Question as Xarelto Cases Continue to Rise

While July 2016 has seen the total number of Xarelto lawsuits approach the 6,000 mark, it will still be several months before evidence against the drug’s manufacturers is presented in court.  But what’s quickly becoming evident is that lawyers will […]

Derek T. Braslow

What’s Really at Risk with Risperdal?

Risperdal has reemerged in headlines recently, after a Philadelphia jury ordered drug-maker Janssen Pharmaceuticals Inc., a Johnson & Johnson subsidiary, to pay a record-setting $70 million in damages to a Tennessee family who alleged their son developed female-like breasts, known […]

Derek T. Braslow

Prilosec, Nexium and Prevacid Put Patients at Risk in More Ways than One

There’s certainly a lot in the news nowadays on the topic of proton pump inhibitors (PPIs) such as Prilosec, Nexium and Prevacid. While these drugs are approved for short-term treatment for Gastroesophageal Reflux Disease, commonly known as GERD, the vast […]